I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn’t touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

| More on:
Caution, careful

Image source: Getty Images

Though I am a big fan of stocks, on the whole, there are many individual stocks I wouldn’t touch with a 60-foot pole. Examples include bankruptcy cases, Russian stocks, and cannabis stocks. It’s not that there aren’t good opportunities in these sectors — there are — it’s just that the quality of the companies in them is so low on average that sifting through the dirt to find a diamond isn’t worth it. In this article, I will explore one TSX stock I wouldn’t touch with a 10- or even 60-foot pole.

Canopy Growth

Canopy Growth (TSX:WEED) is a Canadian cannabis company. It sells marijuana, hashish, edibles, and related products. There was a time when this company was one of the hottest things in town. In the lead-up to legalization in 2018, the company’s stock rallied to incredible highs. However, after legalization hit, it came out that the company was still losing money despite the revenue growth that legalization brought with it. Its stock started crashing then and has been in a secular downtrend ever since then.

No growth

There was a time when Canopy Growth was considered a growth stock. It’s in the company’s name, after all. So, it shouldn’t be surprising that the company did some growing in the old days. However, the growth is no longer in the picture. Because it had to wind down some money-losing business units a few years ago, Canopy’s revenue growth decelerated. In its most recent quarter, it delivered the following:

  • $121 million in revenue, up 2.1% year over year
  • $5.9 million in gross profit, improved from a loss in the year-ago quarter
  • A -$91 million operating loss, improved from $1.8 billion
  • A $41 million net loss
  • -$0.07 in diluted earnings per share (EPS), improved from -$5.24.

As you can see, there was hardly any revenue growth, and all of the earnings figures were negative. On the bright side, the losses narrowed as a percentage of revenue. That doesn’t change the fact that Canopy is rapidly burning through its cash pile, though. In 2018, it got a $5 billion cash infusion from Constellation Brands; as of the last quarter, it was down to $577 million. If it keeps losing money at this rate, then Canopy will eventually run out of balance sheet cash as well. Who knows what that could lead to?

Why Canopy’s earnings are negative

The main reason why Canopy keeps losing money is because it spent untold millions of dollars buying up competitors back in 2018, only for them to prove long-term unprofitable. Despite their lack of profits, these acquired companies nevertheless cost money to run. So, Canopy kept on incurring huge losses just to keep them going. Yet it was selling a commodity (cannabis) that didn’t have very high profit margins. So, it just kept on losing money year after year. This trend continues to this day.

Weed stock: The Foolish takeaway

I suppose it’s possible that Canopy could right its ship someday, but I wouldn’t bet on it. It’s losing money and running out of cash at the same time and is no longer able to attract multi-billion-dollar funding rounds from larger companies. I wouldn’t touch it with a 60-foot pole.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »